Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Silver

Showing results (41-50 of 136) with videos related to

Pageof 14
Sort By:
Plos One|November 28, 2017
Establishment of an indirect ELISA for detection of the novel antifibrotic peptide M10Tanjina Akter, Ilia Atanelishvili, Atsushi Noguchi, et al.
Current Opinion in Rheumatology|September 8, 2012
Racial differences between blacks and whites with systemic sclerosisRichard M Silver, Galina Bogatkevich, Elena Tourkina, et al.
Optics Letters|November 3, 2016
Optimizing the nanoscale quantitative optical imaging of subfield scattering targetsMark-Alexander Henn, Bryan M Barnes, Hui Zhou, et al.
Seminars in Arthritis and Rheumatism|May 20, 2019
Voriconazole-associated periostitis presenting as hypertrophic osteoarthropathy following lung transplantation report of two cases and review of the literatureStephen Elmore, Amy Wisse, Russell W Chapin, et al.
Measurement Science & Technology|October 31, 2024
Combining model-based measurement results of critical dimensions from multiple toolsNien Fan Zhang, Bryan M Barnes, Hui Zhou, et al.
Journal of Computer Assisted Tomography|January 23, 2014
Relationship of main pulmonary artery diameter to pulmonary arterial pressure in scleroderma patients with and without interstitial fibrosisRobert K McCall, James G Ravenel, Paul J Nietert, et al.
Journal of Scleroderma and Related Disorders|February 27, 2025
Anti-fibrotic effects of thrombin inhibition in systemic sclerosis-associated interstitial lung disease: Proof of conceptGalina S Bogatkevich, Terrill J Huggins, Ahmed A Ismail, et al.
The Journal of Rheumatology|October 6, 2005
Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosisPaul J Nietert, Richard M Silver, Holly C Mitchell, et al.
American Journal of Respiratory Cell and Molecular Biology|January 27, 2004
Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilonElena Tourkina, Pal Gooz, James C Oates, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 5, 2008
Proteomic analysis of CTGF-activated lung fibroblasts: identification of IQGAP1 as a key player in lung fibroblast migrationGalina S Bogatkevich, Anna Ludwicka-Bradley, C Beth Singleton, et al.
Pageof 14

Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
Plos One|November 28, 2017
Establishment of an indirect ELISA for detection of the novel antifibrotic peptide M10Tanjina Akter, Ilia Atanelishvili, Atsushi Noguchi, et al.
Current Opinion in Rheumatology|September 8, 2012
Racial differences between blacks and whites with systemic sclerosisRichard M Silver, Galina Bogatkevich, Elena Tourkina, et al.
Optics Letters|November 3, 2016
Optimizing the nanoscale quantitative optical imaging of subfield scattering targetsMark-Alexander Henn, Bryan M Barnes, Hui Zhou, et al.
Seminars in Arthritis and Rheumatism|May 20, 2019
Voriconazole-associated periostitis presenting as hypertrophic osteoarthropathy following lung transplantation report of two cases and review of the literatureStephen Elmore, Amy Wisse, Russell W Chapin, et al.
Measurement Science & Technology|October 31, 2024
Combining model-based measurement results of critical dimensions from multiple toolsNien Fan Zhang, Bryan M Barnes, Hui Zhou, et al.
Journal of Computer Assisted Tomography|January 23, 2014
Relationship of main pulmonary artery diameter to pulmonary arterial pressure in scleroderma patients with and without interstitial fibrosisRobert K McCall, James G Ravenel, Paul J Nietert, et al.
Journal of Scleroderma and Related Disorders|February 27, 2025
Anti-fibrotic effects of thrombin inhibition in systemic sclerosis-associated interstitial lung disease: Proof of conceptGalina S Bogatkevich, Terrill J Huggins, Ahmed A Ismail, et al.
The Journal of Rheumatology|October 6, 2005
Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosisPaul J Nietert, Richard M Silver, Holly C Mitchell, et al.
American Journal of Respiratory Cell and Molecular Biology|January 27, 2004
Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilonElena Tourkina, Pal Gooz, James C Oates, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 5, 2008
Proteomic analysis of CTGF-activated lung fibroblasts: identification of IQGAP1 as a key player in lung fibroblast migrationGalina S Bogatkevich, Anna Ludwicka-Bradley, C Beth Singleton, et al.
Pageof 14